EX-23.2 3 cccc-ex232_46.htm EX-23.2 cccc-ex232_46.htm

Exhibit 23.2

Consent of Independent Registered Public Accounting Firm

 

The Board of Directors
C4 Therapeutics, Inc.:

We consent to the use of our report dated March 11, 2020 incorporated by reference herein.

 

 

/s/ KPMG LLP

 

Boston, Massachusetts

March 11, 2021